Phibro Animal Health Stock Performance
| PAHC Stock | USD 54.89 1.71 3.22% |
Risk-Adjusted Performance
Moderate
Weak | Strong |
Phibro Animal Health currently ranks below 10% of comparable global equities and portfolios when recent risk-adjusted returns are measured across a 90-day horizon. At mid-cap scale, institutional coverage and secondary-market liquidity are typically well established. In spite of rather unsteady technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakout point. Learn More
Relative Risk vs. Return Landscape
If you had invested $ 4,181 in Phibro Animal Health on February 2, 2026 and sold it today you would have earned a total of $ 1,308 from holding Phibro Animal Health or generated 31.28% return on investment over 90 days. Phibro Animal Health is currently generating a 0.4941% daily expected return and carries 3.836% risk (volatility on return distribution) over a 90-day horizon. In relative terms, Phibro exhibits above-average volatility, exceeding roughly 66% of comparable stocks, and PAHC has trailed 91% of traded instruments in return over the 90-day horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
The mean-reverting behavior of Phibro Stock price is a cornerstone of quantitative forecasting models. Studies have found that some stocks are persistently mispriced, with spreads correcting only when dynamics shift. Embedded risk premiums affect the speed at which mispriced stocks converge to their intrinsic value estimates.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 54.89 | 90 days | 54.89 | about 29.38 |
Probability analysis for this stock suggests that the odds of Phibro Animal moving above the current price in 90 days from now are about 29.38 . Recent return data has shown a distribution that skews above the current level over this window. (This density function focuses attention on the most probable trading range for Phibro Stock over the next 90 days).
Phibro Animal Price Density |
| Price |
Predictive Modules for Phibro Animal
The challenge of forecasting Phibro Animal Health mirrors the broader difficulty of predicting stock market movements. While perfect accuracy is unattainable, applying multiple models remains a core part of sound stock analysis. Market surprises are inevitable, but disciplined forecasting still improves investment decision-making.The mean reversion effect in Phibro Animal is stronger when the initial deviation was driven by sentiment rather than fundamentals. Such deviations have sometimes corrected when the initial catalyst fades, though timing remains uncertain. The degree to which Phibro Animal's exhibits mean reversion depends on how efficiently the market prices new information.
Primary Risk Indicators
Over recent decades, the stock market has seen multiple large corrections and recoveries affecting Phibro Animal. Both sharp declines and powerful rallies have tested investor discipline in Phibro Animal Health. Tracking Phibro Animal's volatility and fundamental risk indicators provides a framework for managing downside exposure.α | Alpha over Dow Jones | 0.48 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 3.67 | |
Ir | Information ratio | 0.12 |
Investor Alerts and Insights
Investors who use alerts for Phibro Animal can respond more quickly to important stock events. Checking Phibro Animal Health notifications regularly is a straightforward way to stay on top of actionable developments. Combining Phibro Animal alerts with broader market context improves the quality of investment decisions.| Phibro Animal Health had very high historical volatility over the last 90 days | |
| On 25th of March 2026 Phibro Animal paid $ 0.12 per share dividend to its current shareholders |
Price Density Drivers
For investors analyzing Phibro Animal, understanding buyer and seller positioning dynamics is essential for price analysis. Monitoring these dynamics helps anticipate short-term price movements and gauge current market conditions. Assessing Phibro Animal's price density drivers indicates whether recent moves are fundamental or tactical.
| Common Stock Shares Outstanding | 40.7 M | |
| Cash And Short Term Investments | 77 M |
Phibro Animal Fundamentals Growth
The market value of Phibro Stock depends on how investors perceive Phibro Animal's financial strength. Earnings growth, revenue momentum, profitability ratios, and debt levels drive Phibro Stock valuation. The financial health of Phibro Animal is the primary driver of Phibro Stock market performance over time.
| Return On Equity | 0.32 | |||
| Return On Asset | 0.0834 | |||
| Profit Margin | 0.0629 | |||
| Operating Margin | 0.15 | |||
| Current Valuation | 2.92 B | |||
| Shares Outstanding | 20.62 M | |||
| Price To Earnings | 11.39 X | |||
| Price To Book | 6.69 X | |||
| Price To Sales | 1.52 X | |||
| Revenue | 1.3 B | |||
| EBITDA | 146.85 M | |||
| Cash And Equivalents | 98.67 M | |||
| Cash Per Share | 2.44 X | |||
| Total Debt | 761.55 M | |||
| Debt To Equity | 1.79 % | |||
| Book Value Per Share | 8.20 X | |||
| Cash Flow From Operations | 80.12 M | |||
| Earnings Per Share | 2.26 X | |||
| Total Asset | 1.36 B | |||
| Retained Earnings | 272.7 M | |||
| Current Asset | 342.83 M | |||
| Current Liabilities | 108.78 M | |||
Performance Metrics & Calculation Methodology
Drawdown analysis for Phibro Animal measures how deep losses have been and how long recovery has taken historically. Recovery duration matters as much as drawdown depth in the context of analysis of performance resilience. Phibro Animal shows ROE of 31.8%, ROA of 8.34% (TTM).
Reported values for Phibro Animal Health are derived from periodic company reporting and market reference feeds and standardized for analysis. Return and risk statistics are calculated from historical price series.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board